Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences

SAN FRANCISCO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced that management will participate in three upcoming healthcare conferences in September: 2026 Cantor Global Healthcare Conference Date: Thursday, September 10 Format: Fireside chat and 1x1 meetings Time: 3:55 – 4:25 PM EDT Location: New York, NY Morgan Stanley 24th Annual Global Healthcare Conference Date: Wednesday, September 16 Format: Fireside chat and 1x1 meetings Time: 10:45 – 11:20 AM EDT Location: New York, NY Bernstein’s 3rd Annual Healthcare Forum Date: Wednesday, September 23 Format: Fireside Chat and 1x1 meetings Time: 3:00 – 3:40 PM EDT Location: New York, NY The live and archived webcasts will be accessible from the company’s website at https://ir.structuretx.com/events-presentations/events and replays will be available for at least 90 days. About Structure Therapeutics Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, the Company has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage oral small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more people living with obesity around the world. For additional information, please visit www.structuretx.com. Investors: Corey Davis, Ph.D. LifeSci Advisors, LLC 212-915-2577 [email protected] Jennifer Robinson Structure Therapeutics Inc. [email protected] Media: Dan Budwick 1AB [email protected]